📰 Recursion Pharmaceuticals News
Recursion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recursion Pharmaceuticals. Real-time updates on events, politics, business and more.
July 3, 2024
We just nailed down an eighth straight up day for the dow. Even the nasdaq, okay, it dipped 0. 3 and this is confounding to a lot of people who dont understand that what certain public figures say is not necessarily what they mean. It is s though the whole thing is choreographed like a netflix series, probably rated number eight on the new movies page, and although as exciting market strength is for me, actually, the latter is not so good. So, maybe you better watch it. Let me direct you to the ...
June 7, 2024
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total transaction of $421,000.00. Following the completion of the sale, the chief executive officer now owns […]
June 7, 2024
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of Recursion Pharmaceuticals stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total value of $421,000.00. Following the completion of the transaction, the chief executive officer now directly owns 758,738 […]
June 5, 2024
These Nvidia partner stocks stand to gain from the semiconductor's industry dominance, but they have plenty of upside of their own.
June 4, 2024
Lingotto Investment Management LLP lifted its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 141.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,875,077 shares of the company’s stock after buying an additional 1,100,000 shares during the period. Recursion […]
May 30, 2024
Recursion Pharmaceuticals is an NVIDIA Corp (NASDAQ:NVDA) partner that will use the semiconductor giants chips and technology for drug discovery.
May 29, 2024
Elevatus Welath Management acquired a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 24,650 shares of the company’s stock, valued at approximately $243,000. Other institutional investors also recently bought and sold shares of the […]
May 29, 2024
You don't need to buy her picks, but it's worth understanding them.
May 29, 2024
You're doing something right if your company is worth $2.6 trillion like Nvidia. And it's worth looking at the companies Nvidia invests in.
May 29, 2024
SoundHound AI, an AI voice and conversation platform, has seen its shares rise on pace with the chipmaker this year